GlassScriptPhysician profile
Leonard A Rappaport
NPI 1659381408
$85,097.14
in general payments reported to CMS, 2019-2025
25 companies · $1,458 in 2025
The $1,458 reported for 2025 was more than what 84% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $22K · 2021: $19K · 2022: $13K · 2023: $768 · 2024: $921 · 2025: $1,458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,147.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $66,289.38 | 2019-2021 | |
| Alcon Vision LLC | $13,515.77 | 2019-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Allergan, INC. | $1,206.66 | 2019-2022 | |
| Abbvie INC. | $926.11 | 2022-2025 | |
| New World Medical,INC. | $474.24 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $460.75 | 2022-2025 | Vyzulta, Lotemax Sm, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $397.44 | 2019-2021 | |
| Sight Sciences, INC. | $376.31 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Ivantis, INC | $339.25 | 2019-2020 | |
| Glaukos Corporation | $336.60 | 2024 | Idose, Radius |
| Mallinckrodt Hospital Products INC. | $144.35 | 2025 | Acthar |
| Sun Pharmaceutical Industries INC. | $132.47 | 2019-2024 | |
| Johnson & Johnson Surgical Vision, INC. | $117.40 | 2019-2022 | |
| Shire North American Group INC | $64.04 | 2019 | |
| Thea Pharma INC. | $45.18 | 2025 | Iyuzeh |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $43.40 | 2024 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $39.99 | 2020 | |
| Oasis Medical, INC. | $39.10 | 2019 | |
| Rayner Intraocular Lenses Limited | $37.91 | 2025 | Rayone Emv, Rayone Aspheric, Rayner Cataract Set 1 |
| Dompe US, INC. | $22.82 | 2025 | Oxervate |
| Harrow Eye, LLC | $22.46 | 2024 | Vevye |
| Mallinckrodt Enterprises LLC | $20.74 | 2019 | |
| Kala Pharmaceuticals, INC. | $16.41 | 2019 | |
| Oyster Point Pharma, INC. | $14.67 | 2022 | |
| Eyevance Pharmaceuticals LLC | $13.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Rappaport listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.